Thumbnail
Access Restriction
Open

Author Saygili, Erol ♦ Noor-Ebad, Fawad ♦ Schröder, Jörg W. ♦ Mischke, Karl ♦ Saygili, Esra ♦ Rackauskas, Gediminas ♦ Marx, Nikolaus ♦ Kelm, Malte ♦ Rana, Obaida R.
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword APPLIED LIFE SCIENCES ♦ ANGIOGENESIS ♦ CELL CULTURES ♦ CELL PROLIFERATION ♦ CONCENTRATION RATIO ♦ CONTROL ♦ FIBROBLASTS ♦ GROWTH FACTORS ♦ HEART ♦ HYPERTROPHY ♦ IMMUNOGLOBULINS ♦ ISCHEMIA ♦ MESSENGER-RNA ♦ PATIENTS ♦ PEPTIDES ♦ RATS ♦ SIGNALS ♦ THERAPY
Abstract Background: Autoantibodies have been identified as major predisposing factors for dilated cardiomyopathy (DCM). Patients with DCM show elevated serum levels of vascular endothelial growth factor (VEGF) whose source is unknown. Besides its well-investigated effects on angiogenesis, evidence is present that VEGF signaling is additionally involved in fibroblast proliferation and cardiomyocyte hypertrophy, hence in cardiac remodeling. Whether autoimmune effects in DCM impact cardiac VEGF signaling needs to be elucidated. Methods: Five DCM patients were treated by the immunoadsorption (IA) therapy on five consecutive days. The eluents from the IA columns were collected and prepared for cell culture. Cardiomyocytes from neonatal rats (NRCM) were incubated with increasing DCM-immunoglobulin-G (IgG) concentrations for 48 h. Polyclonal IgG (Venimmun N), which was used to restore IgG plasma levels in DCM patients after the IA therapy was additionally used for control cell culture purposes. Results: Elevated serum levels of VEGF decreased significantly after IA (Serum VEGF (ng/ml); DCM pre-IA: 45 ± 9.1 vs. DCM post–IA: 29 ± 6.7; P < 0.05). In cell culture, pretreatment of NRCM by DCM-IgG induced VEGF expression in a time and dose dependent manner. Biologically active VEGF that was secreted by NRCM significantly increased BNP mRNA levels in control cardiomyocytes and induced cell-proliferation of cultured cardiac fibroblast (Fibroblast proliferation; NRCM medium/HC-IgG: 1 ± 0.0 vs. NRCM medium/DCM-IgG 100 ng/ml: 5.6 ± 0.9; P < 0.05). Conclusion: The present study extends the knowledge about the possible link between autoimmune signaling in DCM and VEGF induction. Whether this observation plays a considerable role in cardiac remodeling during DCM development needs to be further elucidated. - Highlights: • Mechanisms of remodeling in dilated cardiomyopathy (DCM) are not fully understood. • Autoantibodies have been identified as major predisposing factors for DCM. • DCM patients show high serum levels of VEGF. • Recent data indicate that VEGF is involved in cardiac remodeling processes. • Whether autoimmune processes in DCM are involved in VEGF signaling are unclear.
ISSN 0006291X
Educational Use Research
Learning Resource Type Article
Publisher Date 2015-09-11
Publisher Place United States
Journal Biochemical and Biophysical Research Communications
Volume Number 465
Issue Number 1


Open content in new tab

   Open content in new tab